<DOC>
	<DOCNO>NCT01389609</DOCNO>
	<brief_summary>To test bioequivalence Doxazosin 4 Mg Orally-disintegrating Tablet Or Without Water Doxazosin 4 Mg Japanese Marketed Immediate Release Tablet Under Fasted Condition</brief_summary>
	<brief_title>Bioequivalence Study Doxazosin 4 Mg Orally-Disintegrating Tablet With Or Without Water To Doxazosin 4 Mg Japanese Marketed Immediate Release Tablet Under Fasted Condition</brief_title>
	<detailed_description />
	<mesh_term>Doxazosin</mesh_term>
	<criteria>Japanese healthy male subject Baseline orthostatic hypotension define ≥20 mm Hg reduction SBP , ≥10 mm Hg reduction DBP and/or development significant postural symptom ( dizziness , lightheadedness , vertigo ) go supine stand position .</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>Bioequivalence</keyword>
	<keyword>Orally-disintegrating Tablet</keyword>
</DOC>